Strong First Half of 2007 for BCW Index as Cepheid, Invitrogen Shares Post Big Gains | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Shares of Cepheid and Invitrogen topped the list of BCW Index performers in the first half of 2007, while Caliper Life Sciences led the few stocks in the Index that declined (see table below).
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.